• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Gain Therapeutics Inc (NQ: GANX )

    1.140 -0.060 (-5.00%)
    Streaming Delayed Price Updated: 12:32 PM EDT, Jul 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Gain Therapeutics Inc

    < Previous 1 2 3 Next >
    Analyst Expectations for Gain Therapeutics's Future
    Via Benzinga
    Expert Ratings for Gain Therapeutics
    Via Benzinga
    Analyst Ratings for Gain Therapeutics
    Via Benzinga
    Medtronic To $85? Plus Oppenheimer Slashes PT On This Stock By 67%
      
    Via Benzinga
    Heska To $165? Plus BTIG Cuts PT On This Stock By 67%
    BTIG cut the price target on Gain Therapeutics, Inc. (NASDAQ: GANX) from $30 to $10. BTIG analyst Thomas Shrader maintained a Buy rating on the stock. Gain Therapeutics shares rose 1.3% to close at... 
    Via Benzinga
    AMD To Rally Around 39%? Here Are 5 Other Price Target Changes For Monday
    Baird raised Advanced Micro Devices, Inc. (NASDAQ: AMD) price target from $65 to $100. . Baird analyst Tristan Gerra upgraded the stock from Neutral to Outperform. AMD shares rose 5.7% to close at... 
    Via Benzinga
    Gain Therapeutics Touts Additional Encouraging Preclinical Data For Lead Parkinson's Program
    Via Benzinga
    Gain Therapeutics: Q2 Earnings Insights
      Gain Therapeutics (NASDAQ:GANX) reported its Q2 earnings results on Monday, August 8, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Recap: Gain Therapeutics Q1 Earnings
    Gain Therapeutics (NASDAQ:GANX) reported its Q1 earnings results on Monday, May 16, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Gain Therapeutics Shares Skyrocket After Preclinical Data From Parkinson's Program
    Gain Therapeutics Inc (NASDAQ: GANX) has  
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2022
    Upgrades 
    Via Benzinga
    Apple To $185? Here Are 5 Other Price Target Changes For Friday
    Keybanc raised the price target on Apple Inc. (NASDAQ: AAPL) from $177 to $185. However, Keybanc analyst Brandon Nispel maintained the stock with an Overweight. Apple shares fell 0.9% to $172.63 in... 
    Via Benzinga
    Gain Therapeutics: Reasons For Optimism
    In biotechnology, potential rules. And in Gain's case, the potential to not just treat but functionally cure at least some forms of Parkinson's Disease is strong enough to weather early-stage... 
    Via Talk Markets
    Aggregate Insider Buying Remains Elevated For A Third Week $AMH
    In another challenging week for the markets where the Nasdaq dropped nearly 4%, insiders once again significantly stepped up their insider purchases for a third week in a row. We saw an increase across... 
    Via Benzinga
    Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Good morning! We're starting off another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday! 
    Via InvestorPlace
    55 Stocks Moving In Friday's Mid-Day Session
    Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company. 
    Via Benzinga
    92 Biggest Movers From Friday
    Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022
    Upgrades 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Gainers Incannex Healthcare (NASDAQ:IXHL) stock moved upwards by 92.3% to $44.04 during Tuesday's pre-market session. The market value of their outstanding shares is... 
    Via Benzinga
    34 Stocks Moving In Tuesday's Mid-Day Session
    Gainers Biofrontera Inc. (NASDAQ: BFRI) shares climbed 30.7% to $4.4095 after the company provided an update on patient recruitment for the Phase III study for the treatment of... 
    Via Benzinga
    52 Biggest Movers From Yesterday
    Gainers ION Geophysical Corporation (NYSE: IO) shares surged 29.8% to settle at $0.5969. Synaptogenix, Inc. (NASDAQ: SNPX) climbed 29.4% to close at $10.09. Synaptogenix... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    On Wednesday, 41 stocks made new 52-week lows. Facts of Interest About Today's 52-Week Lows: Biogen (NASDAQ:BIIB) was the biggest company by market cap to set a... 
    Via Benzinga
    52 Weeks High And Low Article
    Stocks that Broke Yearly Lows Tuesday Morning During Tuesday's morning trading, 87 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Highs And Lows: 10x... 
    Via Benzinga
    Gain Therapeutics Stock Surges On Positive Preclinical Readout For Neurodegenerative Disease Drugs
    Gain Therapeutics, Inc. (NASDAQ: GANX) shares were trading higher Wednesday after the company presented positive data on two of its lead compounds. What Happened: Bethesda,... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2021
    Upgrades Benchmark upgraded the previous rating for Devon Energy Corp (NYSE: 
    Via Benzinga
    Gain Therapeutics' SEE-Tx™ Platform Shows Increasing Evidence in Treating Diseases Caused by Protein Misfolding
    Image by National Cancer Institute on Unsplash Medical and technological advancements are extending our lifespan. Unfortunately, as human life expectancy rises, so does the risk... 
    Via Benzinga
    The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:... 
    Via Benzinga
    Exposures COVID-19
    The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... 
    Via Benzinga
    Exposures Product Safety
    The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... 
    Via Benzinga
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.